Completed pre-BLA meeting with FDA with full alignment on content of BLA, including CMC module, and path for fourth quarter 2024 rolling BLA submission for PRGN-2012†...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback